Literature DB >> 26545123

Early SIV Dissemination After Intrarectal SIVmac251 Challenge Was Associated With Proliferating Virus-Susceptible Cells in the Colorectum.

Yongjun Sui1, Eun Mi Lee, Yichuan Wang, Alison Hogg, Blake Frey, David Venzon, Ranajit Pal, Jay A Berzofsky.   

Abstract

OBJECTIVE: Few studies have examined the eclipse time of simian immunodeficiency virus/HIV infection through the anal route. We aimed to measure the eclipse time after SIVmac251 intrarectal inoculation, and to investigate the factor(s) associated with early dissemination.
DESIGN: Forty macaques were intrarectally challenged with SIVmac251 3 times at 2-week intervals.
METHODS: Plasma viral RNA was monitored at 4, 7, 11, 14, 21, and 28 days after infection. Rectal/vaginal tissues were obtained and tissue viral loads (VLs) were measured at day 14 postinfection.
RESULTS: Of 40 macaques 26 (65%) had first detectable viral RNAs in the plasma at day 7 after the challenge that led to productive infection. Strikingly, 6 animals (15%) had detectable viral RNA in the plasma as early as at day 4. The Ki67 viral target CD4 T cells in the colorectal tissues were significantly higher in the early or middle-transmitter groups than those in the late-transmitter group. The rectal VL did not correlate with plasma VL at 14-day postinoculation, but did positively correlate with plasma VLs at days 21 and 28 postinfection.
CONCLUSIONS: The median eclipse time after intrarectal challenge was 7 days, with a few early transmitters at 4 days. More rapid viral dissemination was associated with a high frequency of colorectal Ki67CCR5CD4T cells, which fuel the local viral replication. Furthermore, local viral replication in the colorectal tissue during the early stage might affect the plasma VL in a delayed manner. Therefore, to reduce/limit these target cells at the portal of viral entry is essential.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26545123      PMCID: PMC4767727          DOI: 10.1097/QAI.0000000000000890

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  20 in total

1.  Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus.

Authors:  Christopher J Miller; Qingsheng Li; Kristina Abel; Eun-Young Kim; Zhong-Min Ma; Stephen Wietgrefe; Lisa La Franco-Scheuch; Lara Compton; Lijie Duan; Marta Dykhuizen Shore; Mary Zupancic; Marc Busch; John Carlis; Steven Wolinsky; Steven Wolinksy; Ashley T Haase
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

2.  Rapid dissemination of a pathogenic simian/human immunodeficiency virus to systemic organs and active replication in lymphoid tissues following intrarectal infection.

Authors:  Ariko Miyake; Kentaro Ibuki; Yoshimi Enose; Hajime Suzuki; Reii Horiuchi; Makiko Motohara; Naoki Saito; Tadashi Nakasone; Mitsuo Honda; Toshiki Watanabe; Tomoyuki Miura; Masanori Hayami
Journal:  J Gen Virol       Date:  2006-05       Impact factor: 3.891

3.  Virus-host mucosal interactions during early SIV rectal transmission.

Authors:  Wuxun Lu; Fangrui Ma; Alexander Churbanov; Yanmin Wan; Yue Li; Guobin Kang; Zhe Yuan; Dong Wang; Chi Zhang; Jianqing Xu; Mark Lewis; Qingsheng Li
Journal:  Virology       Date:  2014-08-14       Impact factor: 3.616

4.  Microarray analysis of HIV resistant female sex workers reveal a gene expression signature pattern reminiscent of a lowered immune activation state.

Authors:  Elijah M Songok; Ma Luo; Ben Liang; Paul Mclaren; Nadine Kaefer; Winnie Apidi; Genevieve Boucher; Joshua Kimani; Charles Wachihi; Rafick Sekaly; Keith Fowke; Blake T Ball; Francis A Plummer
Journal:  PLoS One       Date:  2012-01-26       Impact factor: 3.240

5.  TLR agonists and/or IL-15 adjuvanted mucosal SIV vaccine reduced gut CD4⁺ memory T cell loss in SIVmac251-challenged rhesus macaques.

Authors:  Yongjun Sui; Susan Gagnon; Amiran Dzutsev; Qing Zhu; Huifeng Yu; Alison Hogg; Yichuan Wang; Zheng Xia; Igor M Belyakov; David Venzon; Dennis Klinman; Warren Strober; Brian Kelsall; Genoveffa Franchini; Jay A Berzofsky
Journal:  Vaccine       Date:  2011-10-29       Impact factor: 3.641

Review 6.  Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection.

Authors:  S D Lawn; S T Butera; T M Folks
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

7.  Low-level CD4+ T cell activation is associated with low susceptibility to HIV-1 infection.

Authors:  Fransje A Koning; Sigrid A Otto; Mette D Hazenberg; Linda Dekker; Maria Prins; Frank Miedema; Hanneke Schuitemaker
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

8.  Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.

Authors:  J V Giorgi; L E Hultin; J A McKeating; T D Johnson; B Owens; L P Jacobson; R Shih; J Lewis; D J Wiley; J P Phair; S M Wolinsky; R Detels
Journal:  J Infect Dis       Date:  1999-04       Impact factor: 5.226

9.  Rapid dissemination of SIV follows multisite entry after rectal inoculation.

Authors:  Patricia Ribeiro Dos Santos; Magali Rancez; Jean-Luc Prétet; Alice Michel-Salzat; Valérie Messent; Anna Bogdanova; Anne Couëdel-Courteille; Evelyne Souil; Rémi Cheynier; Cécile Butor
Journal:  PLoS One       Date:  2011-05-09       Impact factor: 3.240

10.  Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys.

Authors:  James B Whitney; Alison L Hill; Srisowmya Sanisetty; Pablo Penaloza-MacMaster; Jinyan Liu; Mayuri Shetty; Lily Parenteau; Crystal Cabral; Jennifer Shields; Stephen Blackmore; Jeffrey Y Smith; Amanda L Brinkman; Lauren E Peter; Sheeba I Mathew; Kaitlin M Smith; Erica N Borducchi; Daniel I S Rosenbloom; Mark G Lewis; Jillian Hattersley; Bei Li; Joseph Hesselgesser; Romas Geleziunas; Merlin L Robb; Jerome H Kim; Nelson L Michael; Dan H Barouch
Journal:  Nature       Date:  2014-07-20       Impact factor: 49.962

View more
  5 in total

1.  Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody response.

Authors:  Yongjun Sui; George K Lewis; Yichuan Wang; Kurt Berckmueller; Blake Frey; Amiran Dzutsev; Diego Vargas-Inchaustegui; Venkatramanan Mohanram; Thomas Musich; Xiaoying Shen; Anthony DeVico; Timothy Fouts; David Venzon; James Kirk; Robert C Waters; James Talton; Dennis Klinman; John Clements; Georgia D Tomaras; Genoveffa Franchini; Marjorie Robert-Guroff; Giorgio Trinchieri; Robert C Gallo; Jay A Berzofsky
Journal:  J Clin Invest       Date:  2019-02-18       Impact factor: 14.808

2.  Balancing Trained Immunity with Persistent Immune Activation and the Risk of Simian Immunodeficiency Virus Infection in Infant Macaques Vaccinated with Attenuated Mycobacterium tuberculosis or Mycobacterium bovis BCG Vaccine.

Authors:  Kara Jensen; Myra Grace Dela Pena-Ponce; Michael Piatak; Rebecca Shoemaker; Kelli Oswald; William R Jacobs; Glenn Fennelly; Carissa Lucero; Katie R Mollan; Michael G Hudgens; Angela Amedee; Pamela A Kozlowski; Jacob D Estes; Jeffrey D Lifson; Koen K A Van Rompay; Michelle Larsen; Kristina De Paris
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

3.  Microbial Translocation and Inflammation Occur in Hyperacute Immunodeficiency Virus Infection and Compromise Host Control of Virus Replication.

Authors:  Adam J Ericsen; Michael Lauck; Mariel S Mohns; Sarah R DiNapoli; James P Mutschler; Justin M Greene; Jason T Weinfurter; Gabrielle Lehrer-Brey; Trent M Prall; Samantha M Gieger; Connor R Buechler; Kristin A Crosno; Eric J Peterson; Matthew R Reynolds; Roger W Wiseman; Benjamin J Burwitz; Jacob D Estes; Jonah B Sacha; Thomas C Friedrich; Jason M Brenchley; David H O'Connor
Journal:  PLoS Pathog       Date:  2016-12-07       Impact factor: 6.823

4.  Paradoxical myeloid-derived suppressor cell reduction in the bone marrow of SIV chronically infected macaques.

Authors:  Yongjun Sui; Blake Frey; Yichuan Wang; Rolf Billeskov; Shweta Kulkarni; Katherine McKinnon; Tracy Rourke; Linda Fritts; Christopher J Miller; Jay A Berzofsky
Journal:  PLoS Pathog       Date:  2017-05-12       Impact factor: 6.823

5.  Influence of gut microbiome on mucosal immune activation and SHIV viral transmission in naive macaques.

Authors:  Yongjun Sui; Amiran Dzutsev; David Venzon; Blake Frey; Vishal Thovarai; Giorgio Trinchieri; Jay A Berzofsky
Journal:  Mucosal Immunol       Date:  2018-06-01       Impact factor: 7.313

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.